PUBLIC DISCLOSURE & CLARIFICATION

BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.

CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.

Crizotinib liposomes

Inquiry

Cat. No.: X26-05-ZQ2595

Crizotinib liposomes

Name: Crizotinib liposomes
SKU: X26-05-ZQ2595

Inquiry

Synonym: Crizotinib LPs; Crizotinib-loaded liposomes; Crizotinib liposomal nanoparticles

Product Size

100 mg; 250 mg; 500 mg; 1 g; 5 g

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

This formulation features crizotinib liposomes engineered to encapsulate an aminopyridine derivative within a stable vesicle matrix. The structural framework incorporates the hydrophobic tyrosine kinase inhibitor crizotinib directly within the lipophilic hydrocarbon tail domains of a high-purity phospholipid bilayer shell. This precise alignment accommodates the aminopyridine rings within the fluid core, preventing rapid crystallographic phase separation and chemical decomposition of the volatile active agent in open aqueous suspension.

Source

Custom synthesis

Functional Group

Crizotinib

Form

Solid or powder

Purity

≥95%

Impurities

No visible impurities to the naked eye.

Identity

HPLC/MS/NMR

Publications

Publications (0)

Publications

×

Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.